Fuse Biotherapeutics, Inc. — Form D
Fuse Biotherapeutics, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-09. The offering totals $7.1M, of which $2.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-07-09
- Form: D
- Accession: 0001871839-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.1M
- Amount sold: $2.6M
- Remaining: $4.5M
- Investors: 5
- Date of first sale: 2021-06-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-405726
Issuer
- Name: Fuse Biotherapeutics, Inc.
- CIK: 0001871839
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 6080 CENTER DRIVE, LOS ANGELES, CA, 90045
- Phone: 3109918254
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brian Rabinovich | Director | Los Angeles, CA |
| Brian Rabinovich | Executive Officer | Los Angeles, CA |
| Yuanheng Wang Liang | Director | Los Angeles, CA |
| Paul Song | Director | Los Angeles, CA |
| Paul Song | Executive Officer | Los Angeles, CA |
| Jeffrey Takimoto | Executive Officer | Los Angeles, CA |
Other filings by this issuer (2)
More